AIとがん研究 ── 肝臓がん ── 2026-10-20

肝臓がん 1 本。筆頭: AI-driven quantitative assessment of abdominal organs and immunotherapy outcomes across multicenter hepatocellular carcinoma cohorts

対象誌と選び方は索引の頁に

肝臓がんの治療・治験とAI

AI-driven quantitative assessment of abdominal organs and immunotherapy outcomes across multicenter hepatocellular carcinoma cohorts
AI-driven quantitative assessment of abdominal organs and immunotherapy outcomes across multicenter hepatocellular carcinoma cohorts
npj Precision Oncology · 2026-10-17
抄録（全訳）
掲載誌の IF 相当：8.9（OpenAlex の直近 2 年の平均被引用数・2026-10-04 時点の値、2026-10-05 に取得。正式な IF（Clarivate）ではない）
書誌：Li T, Fu X, Guo Y, Wang N, Li S, Guo X, et al. AI-driven quantitative assessment of abdominal organs and immunotherapy outcomes across multicenter hepatocellular carcinoma cohorts. npj Precis Onc. 2026 Oct 17 [Epub ahead of print]. doi:10.1038/s41698-026-01739-w.
確認の範囲：抄録のみ確認

← この号の目次へ